Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J M Lopez Ayala"'
Autor:
A Cordero, D Escribano, B Alvarez-Alvarez, J Martinon, F Garcia-Rondeja, M Rodriguez-Manero, V Bertomeu-Gonzalez, D Cazorla, J Moreno-Arribas, M A Quintanilla, J M Lopez Ayala, P Zuazola, J R Gonzalez-Juanatey
Publikováno v:
European Heart Journal. 43
Background Cholesterol remnants have been identified as one of leading lipid measurements associated with the incidence of coronary heart diseases. Nonetheless, there is scarce evidence on cholesterol remnants distribution in patients with acute coro
Autor:
A Cordero, D Escribano, M A Quintanilla, M Monteagudo, J M Lopez-Ayala, J Moreno-Arribas, E Martinez Rey-Ranal, M D Masia, P Zuazola, V Bertomeu-Gonzalez
Publikováno v:
European Heart Journal. 43
Background Current evidence supports the efficacy of prolonged dual antiplatelet treatment prolonged (DAPT) patients at high-ischemic risk and low bleeding risk. In contrast, several trials have demonstrated the efficacy and safety of short DAPT (1,3
Autor:
David Escribano, Vicente Bertomeu-González, J. Moreno-Arribas, A Cordero, J M Lopez Ayala, Pilar Zuazola, P Perez-Berbell, M Monteagudo, M A Quintanilla
Publikováno v:
European Heart Journal. 42
Background Bleeding events incidence has gained a crucial role in acute coronary patients (ACS) due to its independent effect prognostic value. Methods We assessed the trend of in-hospital and first-year-after-discharge major bleeding events (MB) in
Autor:
A Cordero, D Escribano, V Bertomeu-Gonzalez, J M Lopez-Ayala, M Monteagudo, A M Quintanilla, J Moreno-Arribas, P Perez-Berbell, P Zuazola
Publikováno v:
European Heart Journal. 42
Background Statin plus ezetimibe combination has a recommendation class IIa, level of evidence B, for low-density lipoprotein cholesterol (LDLc) reduction. Since LDLc treatment target for patients with coronary heart disease (CHD) has been recently r
Autor:
J. Moreno-Arribas, A Cordero, M A Quintanilla, Pilar Zuazola, Bertomeu-Gonzalez, J M Lopez Ayala, M Monteagudo, David Escribano, P Perez-Berbell
Publikováno v:
European Heart Journal. 42
Background Polymer-free (PF) stents were designed as an alternative to durable-polymer (DP) drug-eluting stents to minimize the time on dual antiplatelet treatment for patients at high-risk of bleeding. Nonetheless, the efficacy and safety of PF vs.
Autor:
J M, Lopez-Ayala, M, Ortiz-Genga, I, Gomez-Milanes, D, Lopez-Cuenca, F, Ruiz-Espejo, J J, Sanchez-Munoz, M J, Oliva-Sandoval, L, Monserrat, J R, Gimeno
Publikováno v:
Clinical genetics. 88(2)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an important cause of malignant arrhythmia and sudden death particularly in young people. Although it is considered a desmosomal disease, mutations in non-desmosomal genes have also been ident
Autor:
M.A. Fernandez Cascales, C. Perez Ruescas, Juan R. Gimeno, Mariano Valdés, D. Lopez Cuenca, J.P. Hernandez Del Rincon, F. Castro, F. Ruiz Espejo, F. Pastor, J M Lopez Ayala
Publikováno v:
European Heart Journal. 34:P1354-P1354
Background: Sudden Cardiac death is an important health care problem in European countries. Inherited cardiac diseases are common causes in young individuals. We aim to report the preliminary results from a regional programme of sudden cardiac death
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.